|
|
|
|
|
|
|
|
|
|
PLOS ONE: The MDM2 309T>G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 Controls
Conclusions
This meta-analysis provides evidence for the association between MDM2 309 polymorphism and ovarian cancer risk, supporting the hypothesis that MDM2 SNP309 G allele acts as an important ovarian cancer protective factor in Asians but not in Caucasians.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.